Earnings History Data for Arbutus Biopharma Corporation (ABUS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Arbutus Biopharma Corporation

Arbutus Biopharma Corporation is a biopharmaceutical company which is focused on discovering, developing and commercializing a portfolio of drug candidates for chronic hepatitis B infection. The Company's products include TKM-HBV, Cyclophilin Inhibitor-OCB-030, TLR9 Agonist (CYT-003), Capsid Assembly Inhibitors, Surface Antigen Secretion Inhibitors, STING Agonists, cccDNA Formation Inhibitors, cccDNA Epigenetic Modifiers, TKM-PLK1, GI-NET and ACC, HCC, TKM-Ebola, TKM-Ebola-Guinea, TKM-Marburg, TKM-HTG and TKM-ALDH which are in different clinical trial stage. Arbutus Biopharma Corp, formerly known as Tekmira Pharmaceuticals Corporation, is headquartered in Vancouver, BC.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
04-05-2023	PM	7:30 AM ET (May 4)	ABUS	Arbutus Biopharma Corporation	409.38	-0.10	-0.14	-0.11	Arbutus Biopharma GAAP EPS of -$0.10 beats by $0.04, revenue of $6.7M beats by $0.67M [5/4/2023 7:45 AM]	2.54	0.03 (1.20%)	2.50	-0.01 (-0.40%)	1.85 - 3.14	537,593	810,000	1,822
Arbutus Biopharma GAAP EPS of -$0.10 beats by $0.04, revenue of $6.7M beats by $0.67M [5/4/2023 7:45 AM]
02-03-2023	PM	7:30 AM ET (Mar 2)	ABUS	Arbutus Biopharma Corporation	434.70	-0.14	-0.14	-0.15	Arbutus Biopharma GAAP EPS of -$0.46 misses by $0.33, revenue of $39M beats by $32.88M [3/2/2023 7:31 AM]	2.79	-0.02 (-0.53%)	2.80	-0.01 (-0.36%)	1.85 - 3.22	325,456	1,190,000	7,560
Arbutus Biopharma FY 2022 Earnings Preview [3/1/2023 12:39 PM] Arbutus Biopharma GAAP EPS of -$0.46 misses by $0.33, revenue of $39M beats by $32.88M [3/2/2023 7:31 AM]
09-11-2022	PM	7:30 AM ET (Nov 9)	ABUS	Arbutus Biopharma Corporation	364.38	-0.12	-0.12	-0.24	Arbutus Biopharma GAAP EPS of -$0.12 beats by $0.01, revenue of $5.95M misses by $3.23M [11/9/2022 7:40 AM]	2.43	-0.03 (-1.22%)	2.38	-0.08 (-3.25%)	1.85 - 6.50	454,441	1,060,000	18,921
Arbutus Biopharma GAAP EPS of -$0.12 beats by $0.01, revenue of $5.95M misses by $3.23M [11/9/2022 7:40 AM] Arbutus trades higher as Q3 net loss narrows, revenue grows on license deal [11/9/2022 12:26 PM] Arbutus Reports Third Quarter 2022 Financial Results and Provides Corporate Update [Nov-09-22 07:30AM] Arbutus to Present at Jefferies London Healthcare Conference [Nov-08-22 07:30AM]
04-08-2022	PM	7:30 AM ET (Aug 4)	ABUS	Arbutus Biopharma Corporation	355.46	-0.10	-0.13	-0.23	Arbutus Biopharma GAAP EPS of -$0.10 beats by $0.03, revenue of $14.24M beats by $7.47M [8/4/2022 7:33 AM]	2.52	0.06 (2.44%)	2.58	0.12 (4.88%)	1.93 - 6.50	1,469,165	850,000	14,800
Arbutus Biopharma Q2 2022 Earnings Preview [8/3/2022 12:05 PM] Arbutus Biopharma GAAP EPS of -$0.10 beats by $0.03, revenue of $14.24M beats by $7.47M [8/4/2022 7:33 AM]
05-05-2022	PM	7:30 AM ET (May 5)	ABUS	Arbutus Biopharma Corporation	362.90	-0.11	-0.13	-0.21	Arbutus Biopharma GAAP EPS of -$0.11 beats by $0.05, revenue of $12.58M beats by $8.16M [5/5/2022 7:47 AM]	2.55	0.06 (2.41%)	2.55	0.06 (2.41%)	2.26 - 6.50	1,091,977	1,860,521	2,491
Arbutus Biopharma Q1 2022 Earnings Preview [5/4/2022 2:58 PM] Arbutus Biopharma GAAP EPS of -$0.11 beats by $0.05, revenue of $12.58M beats by $8.16M [5/5/2022 7:47 AM] AnaptysBio, Inc. (ANAB) Reports Q1 Loss, Lags Revenue Estimates [May-04-22 06:55PM] Arbutus Reports First Quarter 2022 Financial Results and Provides Corporate Update [May-05-22 07:30AM] Arbutus Biopharma (ABUS) Reports Q1 Loss, Tops Revenue Estimates [May-05-22 08:55AM] Arbutus Biopharma (ABUS) Q1 2022 Earnings Call Transcript [May-05-22 02:30PM]
03-03-2022	PM	7:30 AM ET (Mar 3)	ABUS	Arbutus Biopharma Corporation	467.72	-0.15	-0.16	-0.23	Arbutus Biopharma GAAP EPS of -$0.83 beats by $0.03, revenue of $11M beats by $0.35M [3/3/2022 7:33 AM]	3.06	-0.03 (-0.97%)	3.03	-0.06 (-1.94%)	2.38 - 6.50	1,096,839	2,870,000	7,390
Arbutus Biopharma GAAP EPS of -$0.83 beats by $0.03, revenue of $11M beats by $0.35M [3/3/2022 7:33 AM] Arbutus Reports Fourth Quarter and Year End 2021 Financial Results and Provides Corporate Update [Mar-03-22 07:30AM] Arbutus Biopharma (ABUS) Reports Q4 Loss, Misses Revenue Estimates [Mar-03-22 10:05AM] Arbutus Biopharma (ABUS) Q4 2021 Earnings Call Transcript [Mar-03-22 05:30PM]
04-11-2021	PM	7:30 AM ET (Nov 4)	ABUS	Arbutus Biopharma Corporation	533.25	-0.24	-0.24	-0.27	Arbutus Biopharma EPS in-line, beats on revenue [11/4/2021 7:41 AM]	3.88	0.03 (0.78%)	3.88	0.0 (0.00%)	2.43 - 5.87	1,772,847	1,470,000	5,570
Arbutus Biopharma Q3 2021 Earnings Preview [11/3/2021 12:30 PM] Arbutus Biopharma EPS in-line, beats on revenue [11/4/2021 7:41 AM] Arbutus Reports Third Quarter 2021 Financial Results and Provides Corporate Update [Nov-04-21 07:30AM] Arbutus Biopharma (ABUS) Reports Q3 Loss, Tops Revenue Estimates [Nov-04-21 08:55AM]
05-08-2021	PM	7:30 AM ET (Aug 5)	ABUS	Arbutus Biopharma Corporation	268.27	-0.23	-0.21	-0.25	Arbutus Biopharma EPS misses by $0.01, beats on revenue [8/5/2021 7:32 AM]	3.05	0.29 (10.33%)	2.79	0.03 (1.09%)	2.31 - 5.87	2,362,930	1,080,000	107,930
Arbutus Biopharma EPS misses by $0.01, beats on revenue [8/5/2021 7:32 AM] Arbutus Biopharma shares rise on Q2 topline beat, cash position update [8/5/2021 8:12 AM] Arbutus Reports Second Quarter 2021 Financial Results and Provides Corporate Update [Aug-05-21 07:30AM] Arbutus Biopharma (ABUS) Reports Q2 Loss, Tops Revenue Estimates [Aug-05-21 08:55AM]
05-05-2021	PM	7:30 AM ET (May 5)	ABUS	Arbutus Biopharma Corporation	338.33	-0.21	-0.22	-0.25	Arbutus Biopharma EPS beats by $0.02, misses on revenue [5/5/2021 7:33 AM]	2.96	-0.37 (-11.11%)	3.21	-0.12 (-3.60%)	1.18 - 9.02	2,673,844	1,210,000	27,826
Arbutus Biopharma EPS beats by $0.02, misses on revenue [5/5/2021 7:33 AM] Arbutus Bio slips 4% as Q1 revenue trails consensus [5/5/2021 9:11 AM] Arbutus Biopharma Corp. to Host Earnings Call [May-05-21 06:45AM] Arbutus Reports First Quarter 2021 Financial Results and Provides Corporate Update [May-05-21 07:30AM] Arbutus Biopharma (ABUS) Reports Q1 Loss, Misses Revenue Estimates [May-05-21 08:45AM]
04-03-2021	PM	7:30 AM ET (Mar 4)	ABUS	Arbutus Biopharma Corporation	325.20	-0.23	-0.21	-0.36	Arbutus Biopharma EPS misses by $0.01, beats on revenue [3/4/2021 7:38 AM]	3.12	-0.52 (-14.15%)	3.60	-0.04 (-1.10%)	0.88 - 9.02	4,305,567	2,516,088	47,162
Arbutus Biopharma EPS misses by $0.01, beats on revenue [3/4/2021 7:38 AM] Arbutus posts FY results, timeline updates [3/4/2021 8:11 AM] Arbutus Reports Fourth Quarter and Year End 2020 Financial Results and Provides Corporate Update [Mar-04-21 07:30AM] Arbutus Biopharma Corp. to Host Earnings Call [Mar-04-21 06:45AM] Earnings Preview: Arbutus Biopharma [Mar-03-21 10:42AM] Is a Surprise Coming for Arbutus Biopharma (ABUS) This Earnings Season? [Mar-03-21 08:38AM]
05-11-2020	PM	7:30 AM ET (Nov 5)	ABUS	Arbutus Biopharma Corporation	242.97	-0.27	-0.20	-0.33	Arbutus Biopharma EPS misses by $0.05, misses on revenue [11/5/2020 7:35 AM]	2.87	-0.19 (-6.21%)	2.87	0.0 (0.00%)	0.88 - 9.02	1,553,468	791,224	13,251

07-08-2020	PM	6:00 AM ET (Aug 7)	ABUS	Arbutus Biopharma Corporation	258.61	-0.25	-0.23	-0.46	Arbutus Biopharma EPS misses by $0.01, misses on revenue [8/7/2020 7:31 AM]	3.75	-0.62 (-14.19%)	3.87	-0.50 (-11.44%)	0.82 - 9.02	8,016,791	31,159,284	1,464,899